Most Clicked StoriesMore >


VA suggests limiting prescriptions for new hepatitis C drugs

PCMA SmartBrief | Apr 17, 2014

Doctors should prescribe Gilead's Sovaldi or other costly new hepatitis C drugs for patients awaiting a liver transplant or whose hepatitis is in an advanced stage but should hold off on prescribing the expensive new drugs for other patients, the Department of Veterans Affairs says. Another expert panel in California issued similar recommendations. Kaiser Health News (04/17)


Report: Rx drug spending, use of health care services went up in 2013

PCMA SmartBrief | Apr 15, 2014

CMS' Medicare Part D proposals unite disparate groups against changes

PCMA SmartBrief | Apr 16, 2014

CMS moves to change star ratings in Medicare Part D

PCMA SmartBrief | Apr 18, 2014

Generics reimbursement bill bows to drugstore lobby

PCMA SmartBrief | Apr 15, 2014

Spending on new hepatitis C drug shocks health insurers

PCMA SmartBrief | Apr 18, 2014

Oncologists study relative value of cancer drugs

PCMA SmartBrief | Apr 17, 2014

Insurers work to help people with diabetes stay healthy

PCMA SmartBrief | Apr 14, 2014

Medicare Part D coverage cuts seniors' hospital visits, saves $1.5B yearly, study finds

PCMA SmartBrief | Apr 17, 2014

Ranbaxy problems expose gap in generics approval rules

PCMA SmartBrief | Apr 15, 2014


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more